Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 1, 1998, Pages 83-90

  Darmani, Nissar A ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

5 HT(2A) receptor; Cocaine; d Fenfluramine; GBR 12935; Head twitch response; Nisoxetine; Sertraline

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; COCAINE; DEXFENFLURAMINE; NISOXETINE; SERTRALINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEAD TWITCH; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; STATISTICAL ANALYSIS; TRYPTOPHAN METABOLISM;

1-NAPHTHYLAMINE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; FENFLURAMINE; FLUOXETINE; MALE; MICE; MICE, INBRED ICR; MONOAMINE OXIDASE INHIBITORS; PIPERAZINES; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

ANIMALIA; RODENTIA;

EID: 0032078154     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00548-0     Document Type: Article

References (65)

1. Adell A., Sarna G. S., Hutson P. H., Curzon G. An in vivo dialysis and behavioral study of release of 5-HT by p-chloroamphetamine in reserpine treated rats. Br. J. Pharmacol. 97:1989;206-212.
2. Baumann M. H., Raley T. J., Partilla J. S., Rothman R. B. Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections. A microdissection mapping study Synapse. 14:1993;40-50.
3. Bonanno G., Fassio A., Severi P., Ruelle A., Raiteri M. Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J. Neurochem. 63:1994;1163-1166.
4. 3H GBR 12935. A specific high affinity ligand for labelling dopamine transport complex Eur. J. Pharmacol. 107:1985;289-290.
5. Broderick P. A. Cocaine. On-line analysis of an accumbens amine neural basis for psychomotor behavior Pharmacol. Biochem. Behav. 40:1991;959-968.
6. Carroll M. E., Lac S. T., Asencio M., Kargh R. Intravenous cocaine self-administration in rats is reduced by dietary tryptophan. Psychopharmacology (Berlin). 100:1990;239-300.
7. Carroll M. E., Lac S. T., Asenico M., Kargh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35:1990;237-244.
8. Chen N.-H., Reith M. E. A. Effects of locally applied cocaine, lidocaine and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats. A microdialysis study on monoamine interrelationships J. Neurochem. 63:1994;1701-1713.
9. Curzon G., Fernando J. C. R., Lees A. J. Backward walking and circling. Behavioral responses induced by drug treatments which cause simultaneous release of catecholamines and 5-hydroxytryptamine Br. J. Pharmacol. 66:1979;573-579.
10. Darmani N. A. Differential potentiation of L-tryptophan-induced head-twitch response in mice by cocaine and sertraline. Life Sci. 59:1996;1109-1119.
11. 2-receptor supersensitive mice. Pharmacol. Biochem. Behav. 45:1993;269-274.
12. Darmani N. A. The effects of acute cocaine administration on the DOI-induced head-twitch response in reserpinized mice. Pharmacol. Biochem. Behav. 49:1994;229-232.
13. 2-receptor function. Pharmacol. Biochem. Behav. 41:1992;519-527.
14. 2 receptors? Pharmacol. Biochem. Behav. 36:1990;901-906.
15. 1A receptors. Pharmacol. Biochem. Behav. 38:1991;353-357.
16. 2A-receptor function. Pharmacol. Biochem. Behav. 55:1996;387-396.
17. 2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine Pharmacol. Biochem. Behav. 49:1994;107-113.
18. Fattaccini C. M., Gozlan H., Hamon M. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Neuropharmacology. 30:1991;15-23.
19. Francasso C., Guiso G., Confalonieri S., Bergami A., Garattini S., Caccia S. Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the rat. Neuropharmacology. 34:1995;1653-1659.
20. Friedman E., Gershon S., Rotrosen J. Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain. Br. J. Pharmacol. 54:1975;61-64.
21. Galloway M. P. Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse. 6:1990;63-72.
22. Gartside S. E., Cowen P. J., Sharp T. Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology. 31:1992;9-14.
23. Glennon R. A., Darmani N. A., Martin B. R. Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents. Life Sci. 48:1991;2493-2498.
24. 3H-serotonin. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;1-6.
25. 3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur. J. Pharmacol. 238:1993;9-17.
26. Greengard P., Valtorta F., Czernik A. J., Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science. 259:1993;781-785.
27. Handley S. L., Singh L. Neurotransmitters and shaking behaviour. More than a "gut bath" for the brain Trends Pharmacol. Sci. 7:1986;324-328.
28. Heal D. J., Luscombe G. P., Martin K. F. Pharmacological characterization of 5-HT receptor subtypes using behavioral models. Marsden C. A., Heal D. J. Central serotonin receptors and psychotropic drugs. 1992;56-99 Blackwell Scientific Publications, London.
29. Howell L. L., Bird L. D. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J. Pharmacol. Exp. Ther. 275:1995;1551-1559.
30. Humphrey P. P. A., Hartig P., Hoyer D. A. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14:1993;233-236.
31. 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res. 698:1995;204-208.
32. Invernizzi R. G., Berettera C., Garattini S., Samanin R. D- and L-isomers of fenfluramine differs markedly in their interaction with brain serotonin and catecholamines in the rat. Eur. J. Pharmacol. 120:1986;9-15.
33. Johanson C. E., Fischman M. W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
34. Kalivas P. W., Duffy P. Effects of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse. 5:1990;48-58.
35. Knapp S., Mandell A. J. Narcotic drugs. Effects on serotonin biosynthetic systems of the brain Science. 177:1972;1209-1211.
36. Koe B. K., Weissman A., Welch W. M., Brown R. G. Sertraline, 1S, 4S-N-Methyl-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J. Pharmacol. Exp. Ther. 226:1983;686-690.
37. Kreiss D. S., Wieland S., Lucki I. The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience. 52:1993;295-301.
38. Kuhar M. J., Ritz M. C., Gregoriadis D., Lew R., Sharkey J. A cocaine receptor associated with dopamine transport and drug self-administration. Lakoski J. M., Galloway M. P., White F. J. Cocaine, pharmacology, physiology and clinical strategies. 1992;191-201 CRC Press, Boca Raton, FL.
39. Kuhn D. M., Wolf W. A., Youdim B. H. 5-Hydroxytryptamine release in vivo from a cytoplasmic pool. Studies on the 5-HT behavioral syndrome in reserpinized rats Br. J. Pharmacol. 84:1985;121-129.
40. Li M. Y., Yan Q. S., Coffey L. L., Reith M. E. Extracellular dopamine, norepinephrine and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamne uptake blockers. J. Neurochem. 66:1996;559-568.
41. Mattia A., Lecesse A. P., Morton J. E. Effects of quipazine on cocaine self-administration in rats. Pharmacologist. 28:1986;151-156.
42. McGregor A., Locosta S., Roberts D. C. S. Tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat. Pharmacol. Biochem. Behav. 44:1993;651-655.
43. Murdock D., McTavish D. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder Drugs. 44:1992;604-624.
44. 3 mediated control of dopamine function. Psychopharmacology (Berlin). 112(Suppl. 1):1993;S66-S67.
45. Parsons L. H., Justice J. B. Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
46. Pawlowski L., Ruzynska J., Crórka Z. Citalopram. A new inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties Psychopharmacology (Berlin). 74:1981;161-165.
47. Raiteri M., Bonanno G., Vallebuona F. In vitro and in vivo effects of d-fenfluramine. No apparent relation between 5-hydroxytryptamine release and hypophagia J. Pharmacol. Exp. Ther. 273:1995;643-649.
48. Reith M. E. A., de Costa B., Rice K. C., Jacobson A. E. Evidence for mutually exclusive binding of cocaine, BTCP, GBR 129355, and dopamine to the dopamine transporter. Eur. J. Pharmacol. 227:1992;417-425.
49. Richardson N. R., Roberts D. C. S. Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci. 49:1991;833-840.
50. Richelson E., Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes. Most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104:1984;277-286.
51. Ritz M. C., Lamb R. J., Goldberg S. R., Kuhar M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
52. 125] RTI-55. J. Pharmacol. Exp. Ther. 270:1994;296-309.
53. Sabol K. E., Richards J. B., Seiden L. S. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res. 585:1992;421-424.
54. 2 receptors reduces the increase in extracellular concentration produced by amphetamine analogue 3,4-methylenedioxymethamphetamine. J. Neurochem. 62:1994;1382-1389.
55. 2A receptor antagonist, MDL 100 907, increases dopamine efflux in the prefrontal cortex in the rat. Eur. J. Pharmacol. 273:1995;273-279.
56. 1A agonists J. Pharmacol. Exp. Ther. 273:1995;101-112.
57. Singleton C., Marsden C. A. Circadian variation in the head-twitch response produced by 5-methoxy-N, N-dimethyltryptamine and p-chloroamphetamine in the mouse. Psychopharmacology (Berlin). 74:1981;173-176.
58. Sterakna L. R., Sanders-Bush E. Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons. Biochem. Pharmacol. 28:1979;3103-3107.
59. Sulzer D., Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules. A mechanism of action Neuron. 5:1990;797-808.
60. 3H-nisoxetine. A new radioligand for norepinephrine uptake sites in brain Eur. J. Pharmacol. 191:1990;239-243.
61. Tella S. R., Goldberg S. R. Monoamine uptake inhibitors alter cocaine pharmacokinetics. Psychopharmacology (Berlin). 112:1993;497-502.
62. Theoharides T. C., Bondy P. K., Tsakalos N. D., Ashkenase P. W. Differential release of serotonin and histamine from mast cells. Nature. 297:1982;229-231.
63. Trulson M. E., Jacobs B. L. Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur. J. Pharmacol. 36:1976;149-154.
64. Vetulani J., Bednarczyk B., Reichenberg K., Rokosz A. Head-twitches induced by LSD and quipazine. Similarities and differences Neuropharmacology. 19:1980;155-158.
65. Wölfel R., Graefe K.-H. Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;129-136.